Borderline Personality Disorder
Course #66222 -
- Participation Instructions
- Review the course material online or in print.
- Complete the course evaluation.
- Review your Transcript to view and print your Certificate of Completion. Your date of completion will be the date (Pacific Time) the course was electronically submitted for credit, with no exceptions. Partial credit is not available.
Borderline personality disorder is a severe, complex psychiatric disorder characterized by long-standing patterns of disproportionately intense emotions, impulsive and self-destructive behaviors. Mental health providers tend to harbor negative and harsh attitudes toward patients with BPD and endorse low ratings on empathy, comfort and treatment, and overall prognosis, which can negatively affect the care and treatment outcome of these patients. It is imperative for these providers to receive education regarding the nature of BPD, effective drug and non-drug therapies, and perhaps most importantly, interaction strategies to avoid being drawn into the patient's pathologic personality traits.
- INTRODUCTION
- HISTORY OF BORDERLINE PERSONALITY DISORDER
- DIAGNOSTIC CRITERIA
- EPIDEMIOLOGY
- PATHOGENESIS AND PATHOPHYSIOLOGY
- NATURAL HISTORY
- BARRIERS TO CARE
- ASSESSMENT AND DIAGNOSIS
- GENERAL TREATMENT CONSIDERATIONS
- PSYCHOSOCIAL THERAPIES
- PHARMACOTHERAPY
- ADDRESSING THE FAMILY
- TREATMENT OF COMORBIDITIES
- PATIENT PROGNOSIS
- CONCLUSION
- RESOURCES
- Works Cited
- Evidence-Based Practice Recommendations Citations
This course is designed for psychologists who are involved in the care of patients with borderline personality disorder.
The purpose of this course is to provide psychologists with the information necessary to assess and treat patients with borderline personality disorder effectively and safely, while minimizing their own stress level and clinic disruption these patients are capable of producing.
Upon completion of this course, you should be able to:
- Review the history of borderline personality disorder (BPD).
- Describe the current and previous diagnostic criteria for BPD.
- Outline the incidence and prevalence of BPD.
- Identify common psychiatric and medical comorbidities of BPD.
- Evaluate the pathophysiology and natural history of BPD in various patients.
- Analyze barriers to the care of patients with BPD.
- Discuss approaches to the assessment and diagnosis of BPD.
- Describe conditions to consider in the differential diagnosis of BPD.
- Outline the history of therapy for BPD and selection of the appropriate level of care for patients with BPD.
- Discuss approaches to identify and intervene to prevent self-harm, parasuicidal behaviors, and suicide in patients with BPD.
- Assess the efficacy of available specialist psychosocial therapies used in the treatment of BPD.
- Evaluate the efficacy of available generalist and primary care interventions used in the treatment of BPD.
- Review the role of pharmacotherapy in BPD treatment, including contraindicated medications.
- Describe the importance of involving the family in treatment approaches for BPD.
- Discuss approaches to managing psychiatric comorbidities in patients with BPD.
- Outline the prognosis of patients with BPD.
Mark Rose, BS, MA, LP, is a licensed psychologist in the State of Minnesota with a private consulting practice and a medical research analyst with a biomedical communications firm. Earlier healthcare technology assessment work led to medical device and pharmaceutical sector experience in new product development involving cancer ablative devices and pain therapeutics. Along with substantial experience in addiction research, Mr. Rose has contributed to the authorship of numerous papers on CNS, oncology, and other medical disorders. He is the lead author of papers published in peer-reviewed addiction, psychiatry, and pain medicine journals and has written books on prescription opioids and alcoholism published by the Hazelden Foundation. He also serves as an Expert Advisor and Expert Witness to law firms that represent disability claimants or criminal defendants on cases related to chronic pain, psychiatric/substance use disorders, and acute pharmacologic/toxicologic effects. Mr. Rose is on the Board of Directors of the Minneapolis-based International Institute of Anti-Aging Medicine and is a member of several professional organizations.
Contributing faculty, Mark Rose, BS, MA, LP, has disclosed no relevant financial relationship with any product manufacturer or service provider mentioned.
Margaret Donohue, PhD
The division planner has disclosed no relevant financial relationship with any product manufacturer or service provider mentioned.
Sarah Campbell
The Director of Development and Academic Affairs has disclosed no relevant financial relationship with any product manufacturer or service provider mentioned.
The purpose of NetCE is to provide challenging curricula to assist healthcare professionals to raise their levels of expertise while fulfilling their continuing education requirements, thereby improving the quality of healthcare.
Our contributing faculty members have taken care to ensure that the information and recommendations are accurate and compatible with the standards generally accepted at the time of publication. The publisher disclaims any liability, loss or damage incurred as a consequence, directly or indirectly, of the use and application of any of the contents. Participants are cautioned about the potential risk of using limited knowledge when integrating new techniques into practice.
It is the policy of NetCE not to accept commercial support. Furthermore, commercial interests are prohibited from distributing or providing access to this activity to learners.
Supported browsers for Windows include Microsoft Internet Explorer 9.0 and up, Mozilla Firefox 3.0 and up, Opera 9.0 and up, and Google Chrome. Supported browsers for Macintosh include Safari, Mozilla Firefox 3.0 and up, Opera 9.0 and up, and Google Chrome. Other operating systems and browsers that include complete implementations of ECMAScript edition 3 and CSS 2.0 may work, but are not supported. Supported browsers must utilize the TLS encryption protocol v1.1 or v1.2 in order to connect to pages that require a secured HTTPS connection. TLS v1.0 is not supported.
The role of implicit biases on healthcare outcomes has become a concern, as there is some evidence that implicit biases contribute to health disparities, professionals' attitudes toward and interactions with patients, quality of care, diagnoses, and treatment decisions. This may produce differences in help-seeking, diagnoses, and ultimately treatments and interventions. Implicit biases may also unwittingly produce professional behaviors, attitudes, and interactions that reduce patients' trust and comfort with their provider, leading to earlier termination of visits and/or reduced adherence and follow-up. Disadvantaged groups are marginalized in the healthcare system and vulnerable on multiple levels; health professionals' implicit biases can further exacerbate these existing disadvantages.
Interventions or strategies designed to reduce implicit bias may be categorized as change-based or control-based. Change-based interventions focus on reducing or changing cognitive associations underlying implicit biases. These interventions might include challenging stereotypes. Conversely, control-based interventions involve reducing the effects of the implicit bias on the individual's behaviors. These strategies include increasing awareness of biased thoughts and responses. The two types of interventions are not mutually exclusive and may be used synergistically.